Sun Pharma's New Leadership Era Begins

In a strategic move to ensure stability and growth, Sun Pharma, India's largest drug maker and the world's fourth-largest generic company, has elevated Aalok Shanghvi, son of founder Dilip Shanghvi, to the role of Chief Operating Officer. This significant appointment marks a pivotal step in the company's succession planning, highlighting the trust in the next generation to steer the company towards a prosperous future.

Under the leadership of promoter Dilip Shanghvi, who serves as the company's chairman and managing director, Sun Pharma continues to expand its global footprint. Aalok's sibling, Vidhi, also plays a crucial role in the company, heading the domestic consumer healthcare business. Together with top executives like Abhay Gandhi, CEO North America, and India business head, Kirti Ganorkar, the company is poised for continued success and innovation in the pharmaceutical industry.